<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18439386</article-id>
      <article-id pub-id-type="pmc">2600244</article-id>
      <article-id pub-id-type="publisher-id">07-0433</article-id>
      <article-id pub-id-type="doi">10.3201/eid1405.070433</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Leishmania (Leishmania) amazonenis</italic> Infection, Suriname</article-title>
        <alt-title alt-title-type="running-head">Leishmaniasis, Suriname</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>van der Meide</surname>
            <given-names>Wendy</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Vries</surname>
            <given-names>Henry</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
          <xref ref-type="aff" rid="aff3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pratlong</surname>
            <given-names>Francine</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van der Wal</surname>
            <given-names>Allard</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sabajo</surname>
            <given-names>Leslie</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">&#xB6;</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Royal Tropical Institute, Amsterdam, the Netherlands</aff>
        <aff id="aff2"><label>&#x2020;</label>Academic Medical Center, Amsterdam, the Netherlands</aff>
        <aff id="aff3"><label>&#x2021;</label>Health Service Amsterdam, Amsterdam, the Netherlands</aff>
        <aff id="aff4"><label>&#xA7;</label>Centre National de R&#xE9;f&#xE9;rence des <italic>Leishmania</italic> and Universit&#xE9; Montpellier, Montpellier, France</aff>
        <aff id="aff5"><label>&#xB6;</label>Dermatology Service, Paramaribo, Suriname</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Wendy van der Meide, Koninklijk Instituut voor de Tropen/Royal Tropical Institute, KIT Biomedical Research, Meibergdreef 39, 1105 AZ, Amsterdam, the Netherlands; email: <email xlink:href="wfmeide@yahoo.com">wfmeide@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <issue>5</issue>
      <fpage>857</fpage>
      <lpage>859</lpage>
      <kwd-group kwd-group-type="author" xml:lang="EN">
        <title>Keywords: </title>
        <kwd>Leishmania L. amazonenis</kwd>
        <kwd>Suriname</kwd>
        <kwd>miltefosine</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> A 17-year-old man was seen at the Dermatology Service in Paramaribo (Suriname) with a skin condition that he had had since he was 5 years of age. The condition consisted of multiple cutaneous ulcerations, nodules, and fibrotic plaques disseminated on his face, limbs, and trunk, and subcutaneous nodules on lymph-draining tracts on his hands, arms, and legs (<xref ref-type="local-data" rid="SD1">Appendix Figure</xref>, panel<bold> A</bold>). He had lived his entire life in an inland village, located at Brokopondo Lake (central-eastern Suriname); he had never traveled outside the country. The diagnosis of cutaneous leishmaniasis (CL, a parasitic disease caused by the protozoa <italic>Leishmania</italic>) was presumed. The patient received pentamidine therapy in 1997, 1998, and 2005, but without sustained clinical effect. Rapid screening tests for HIV were negative (Determine [Abbott Laboratories, Tokyo, Japan] and Unigold [Trinity Biotech, Co. Wicklow, Ireland]). In 2006, the diagnosis of CL was confirmed with histopathology, culture, and PCR. The parasite was identified by a PCR restriction fragment length polymorphism method on the small subunit&#x2013;internal transcribed spacer genes (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>) and by multilocus enzyme electrophoresis at the National Reference Center of <italic>Leishmania</italic> (Montpellier, France).</p>
    <p>After promising results were obtained with miltefosine in a patient with anergic diffuse cutaneous leishmaniasis (ADCL) in Venezuela (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>), the patient received 150 mg/day oral miltefosine (Impavido, Zentaris, Germany) for 98 days and the lesional parasite load was quantified with quantitative nucleic acid sequence-based amplification (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Skin biopsy specimens were collected from 1 target lesion before treatment; during treatment at day 14, day 28, day 42 (all in duplicate); and at day 70 (single biopsy).</p>
    <p>The strain causing infection (MHOM/SR/2006/SP100) was identified as <italic>Leishmania (Leishmania) amazonensis,</italic> and the enzymatic profile was equal to <italic>L. (L.) amazonensis</italic> zymodeme MON-41. Histopathology showed large macrophages containing abundant <italic>Leishmania</italic> amastigotes and few lymphocytes and plasma cells without granuloma formation. A considerable clinical improvement was observed during the first 2 months of therapy. The lesions slowly decreased in size and duration. At day 70, all ulcerative lesions were re-epithelialized, without signs of infiltration or lymphangitis (<xref ref-type="local-data" rid="SD1">Appendix Figure</xref>, panel<bold> B</bold>). At start of treatment, parasite counts of 360,000 and 310,000 parasites per biopsy were detected; these counts decreased to 0 parasites/biopsy at day 70. Histopathologic studies at day 70 showed no <italic>Leishmania</italic> bodies, a dense lymphocytic and plasma cellular infiltrate, and fibrosis. Apart from mild elevation of creatine and urea during treatment, no subjective or adverse side effects were reported.</p>
    <p><italic>L. (L.) amazonensis</italic> causes CL and 2 very serious manifestations of CL, disseminated cutaneous leishmaniasis (DCL) and ADCL (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Both forms are histopathologically characterized by heavily parasitized macrophages and an absence of cell-mediated immune responses in therapy-naive patients (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). ADCL is resistant to any form of therapy, and cell-mediated immune responses never seem to occur. In contrast, the cell-mediated immune response in DCL can eventually arise upon therapy response, even in patients with previous therapy failures (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). The therapy response in DCL patients is histopathologically characterized by the appearance of a lymphocytic and plasma cellular infiltrate. The diagnosis of DCL is plausible in our patient based on the histopathologic findings before, during, and after therapy; the clinical picture (erythematous infiltrated plaques, lymphadenitis, and lymphangitis), and the favorable therapy response. He was last seen 7 months after end of therapy, at which time new lesions had not developed.</p>
    <p>In general, <italic>L. (L.) amazonensis</italic> infection is rare in humans (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). In French Guiana, bordering the eastern side of Suriname, few patients (&#x2248;1.9%) are reported to be infected with this species (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). However, the sandfly vector of <italic>L. (L.) amazonensis</italic>, <italic>Lutzomyia flaviscutellata,</italic> was detected earlier in Suriname (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>), which may indicate transmission of <italic>L. (L.) amazonensis</italic> infection to humans by means of the bite of this sandfly in Suriname. Our patient had no history of transfusion or intravenous drug use.</p>
    <p>Many gold diggers from the northern part of Brazil work and travel in Suriname and are familiar with CL. In the Brazilian State Par&#xE1;, a region bordering Suriname in the South, the infection rate with <italic>L. (L.) amazonensis</italic> is high (34.8%) (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). It is thus conceivable that infected gold diggers from that area have introduced <italic>L. (L.) amazonensis</italic> into Suriname. Our patient used to live in a village where many Brazilian gold diggers worked around the time that his skin lesions developed. Migration of laborers is associated with an increased risk for CL infection (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). The zymodeme MON-41 is widespread in Central America and the northern part of South America, and has been reported in Venezuela, Brazil, Panama, French Guiana, and Colombia (F. Pratlong and J.P. Dedet, Montpellier International Cryobank of <italic>Leishmania</italic>, pers. comm., 2007). Therefore, speculations on the exact origin of the infection need to be made cautiously.</p>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <caption>
          <title>Appendix Figure</title>
          <p>Infiltrated lesions on the patient's hands A) before and B) 70 days after treatment began.</p>
        </caption>
        <media xlink:href="07-0433_app-s1.gif" xlink:type="simple" id="N0x229f400N0x222d5d0" position="anchor" mimetype="image" mime-subtype="gif"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: van der Meide W, de Vries H, Pratlong F, van der Wal A, Sabajo L. <italic>Leishmania (Leishmania)</italic> <italic>amazonenis</italic> infection, Suriname [letter]. Emerg Infect Dis [serial on the Internet]. 2008 May [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/EID/content/14/5/857.htm">http://www.cdc.gov/EID/content/14/5/857.htm</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>Miltefosine (Impavido) was kindly donated by Zentaris (Germany) at the request of Pieter van Thiel. We thank J.P Dedet, W.R. Faber, and H.D.F.H. Schallig for critical reading of the manuscript.</p>
      <p>This work was supported by a grant from the Netherlands Foundation for the Advancement of Tropical Research (WOTRO contract 96-210).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <citation citation-type="journal"><string-name><surname>Rotureau</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ravel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Couppi&#xE9;</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pratlong</surname> <given-names>F</given-names></string-name>, <string-name><surname>Nacher</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dedet</surname> <given-names>JP</given-names></string-name>, <etal/><article-title>Use of PCR-restriction fragment length polymorphism analysis to identify the main New World <italic>Leishmania</italic> species and analyze their taxonomic properties and polymorphism by application of the assay to clinical samples.</article-title><source>J Clin Microbiol</source> <year>2006</year>;<volume>44</volume>:<fpage>459</fpage>&#x2013;<lpage>67</lpage> <pub-id pub-id-type="doi">10.1128/JCM.44.2.459-467.2006</pub-id><pub-id pub-id-type="pmid">16455899</pub-id></citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <citation citation-type="journal"><string-name><surname>Zerpa</surname> <given-names>O</given-names></string-name>, <string-name><surname>Blanco</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kannee</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ulrich</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sindermann</surname> <given-names>H</given-names></string-name>, <string-name><surname>Engel</surname> <given-names>J</given-names></string-name>, <etal/><article-title>Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report.</article-title><source>Int J Dermatol</source> <year>2006</year>;<volume>45</volume>:<fpage>751</fpage>&#x2013;<lpage>3</lpage> <pub-id pub-id-type="doi">10.1111/j.1365-4632.2006.02751.x</pub-id><pub-id pub-id-type="pmid">16796642</pub-id></citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <citation citation-type="journal"><string-name><surname>van der Meide</surname> <given-names>WF</given-names></string-name>, <string-name><surname>Schoone</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Faber</surname> <given-names>WR</given-names></string-name>, <string-name><surname>Zeegelaar</surname> <given-names>JE</given-names></string-name>, <string-name><surname>de Vries</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Ozbel</surname> <given-names>Y</given-names></string-name>, <etal/><article-title>Quantitative nucleic acid sequence-based assay as a new molecular tool for the detection and quantification of <italic>Leishmania</italic> parasites in skin biopsies.</article-title><source>J Clin Microbiol</source> <year>2005</year>;<volume>43</volume>:<fpage>5560</fpage>&#x2013;<lpage>6</lpage> <pub-id pub-id-type="doi">10.1128/JCM.43.11.5560-5566.2005</pub-id><pub-id pub-id-type="pmid">16272487</pub-id></citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <citation citation-type="journal"><string-name><surname>Silveira</surname> <given-names>FT</given-names></string-name>, <string-name><surname>Lainson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Corbett</surname> <given-names>CE</given-names></string-name> <article-title>Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by <italic>Leishmania (Leishmania) amazonensis.</italic></article-title><source>Mem Inst Oswaldo Cruz</source> <year>2005</year>;<volume>100</volume>:<fpage>525</fpage>&#x2013;<lpage>34</lpage> <pub-id pub-id-type="doi">10.1590/S0074-02762005000500013</pub-id><pub-id pub-id-type="pmid">16184231</pub-id></citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <citation citation-type="journal"><string-name><surname>Rotureau</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ravel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Nacher</surname> <given-names>M</given-names></string-name>, <string-name><surname>Couppi&#xE9;</surname> <given-names>P</given-names></string-name>, <string-name><surname>Curtet</surname> <given-names>I</given-names></string-name>, <string-name><surname>Dedet</surname> <given-names>JP</given-names></string-name>, <etal/><article-title>Molecular epidemiology of <italic>Leishmania (Viannia) guyanensis</italic> in French Guiana.</article-title><source>J Clin Microbiol</source> <year>2006</year>;<volume>44</volume>:<fpage>468</fpage>&#x2013;<lpage>73</lpage> <pub-id pub-id-type="doi">10.1128/JCM.44.2.468-473.2006</pub-id><pub-id pub-id-type="pmid">16455900</pub-id></citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <citation citation-type="journal"><string-name><surname>Burgos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hudson</surname> <given-names>J</given-names></string-name> <article-title>Annotated list of the phlebotominae (diptera) of Suriname.</article-title><source>Mem Inst Oswaldo Cruz</source> <year>1994</year>;<volume>89</volume>:<fpage>171</fpage>&#x2013;<lpage>8</lpage></citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <citation citation-type="journal"><string-name><surname>Silveira</surname> <given-names>FT</given-names></string-name>, <string-name><surname>Lainson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Shaw</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>De Souza</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Ishikawa</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Braga</surname> <given-names>RR</given-names></string-name> <article-title>Cutaneous leishmaniasis due to <italic>Leishmania (Leishmania) amazonensis</italic> in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections.</article-title><source>Trans R Soc Trop Med Hyg</source> <year>1991</year>;<volume>85</volume>:<fpage>735</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1016/0035-9203(91)90437-4</pub-id><pub-id pub-id-type="pmid">1801340</pub-id></citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <citation citation-type="journal"><string-name><surname>Rotureau</surname> <given-names>B</given-names></string-name>, <string-name><surname>Joubert</surname> <given-names>M</given-names></string-name>, <string-name><surname>Clyti</surname> <given-names>E</given-names></string-name>, <string-name><surname>Djossou</surname> <given-names>F</given-names></string-name>, <string-name><surname>Carme</surname> <given-names>B</given-names></string-name> <article-title>Leishmaniasis among gold miners, French Guiana.</article-title><source>Emerg Infect Dis</source> <year>2006</year>;<volume>12</volume>:<fpage>1169</fpage>&#x2013;<lpage>70</lpage><pub-id pub-id-type="pmid">16848045</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
